Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes ...

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...

Currently, blood-based screening is mostly appropriate for high-risk groups, such as: Prostate cancer: Men over 50 may ...

It involves the following characteristics: Stage grouping: T1 or T2, N0, M0 Stage 1 colon cancer has progressed to a tumor, ...

Colorectal cancer (CRC ... DNA change that some people carry-affects how intratumoral microbiota adhere to tumor cells, promoting CRC progression. These findings were published in Cell Host ...

Hulick's tumor markers indicated the presence of mismatch ... and there wasn't an equivalent study for colon cancer. But Sahin thought that the study was dramatic enough—and Hulick's cancer ...

Vitamin D’s anti-cancer powers go beyond bones, new findings reveal how it suppresses inflammation, boosts immune surveillance, and disrupts tumor development to guard against colorectal cancer.

In combination with established tumor markers, EDTA-plasma Tumor M2-PK ... PK testing is a good noninvasive screening parameter for colorectal cancer with a reported sensitivity of 68.8-91.0% ...